Efficacy of epidermal growth factor receptor targeting in advanced chordoma: Case report and literature review

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Launay, Simon G ^a   Chetaille, Bruno ^a   Medina, Fanny ^a   Perrot, Delphine ^a   Nazarian, Serge ^b   Guiramand, Jérôme ^a   Moureau Zabotto, Laurence ^a   Bertucci, François ^a,c  

^a INSTITUT PAOLI CALMETTES   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; IMATINIB; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CASE REPORT; CERVICAL LYMPH NODE; CHORDOMA; CHROMOSOME 7; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TARGETING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE FRACTIONATION; SPINE SURGERY; TRISOMY; BONE TUMOR; CANCER STAGING; DRUG ANTAGONISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHORDOMA; HUMANS; MALE; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 80053503747     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-423     Document Type: Article

References (18)

1. Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol 2007, 19:367-370. 10.1097/CCO.0b013e3281214448, 17545801.
2. Heaton JM, Turner DR. Reflections on notochordal differentiation arising from a study of chordomas. Histopathology 1985, 9:543-550. 10.1111/j.1365-2559.1985.tb02835.x, 4007792.
3. Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res 2006, 12:6920-6928. 10.1158/1078-0432.CCR-06-1584, 17145809.
4. Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Imatinib mesylate in chordoma. Cancer 2004, 101:2086-2097. 10.1002/cncr.20618, 15372471.
5. Casali PG, Stacchiotti S, Grosso F, Messina A, Crippa F, Tamborini E, Bertieri R, Collini S, Pilotti S, Gronchi A. Adding cisplatin (CDDP) to imatinib (IM) restablishes tumor response following secondary resistance to IM in advanced chordoma. J Clin Oncol 2007, 25. 2007 ASCO Annual Meeting Proceedings, Abstract 10038.
6. Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A, Crippa F, Morosi C, Gronchi A, Pilotti S, Casali PG. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 2009, 20:1886-1894. 10.1093/annonc/mdp210, 19570961.
7. Cataldo VD, Gibbons DL, Pérez-Soler R, Quintas-Cardama A. Treatment of non-small-cell lung cancer with erlotinib and gefitinib. N Engl J Med 2011, 364:947-955. 10.1056/NEJMct0807960, 21388312.
8. Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 2006, 29:572-574. 10.1159/000096283, 17202828.
9. Linden O, Stenberg L, Kjellen E. Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib. Acta Oncol 2009, 48:158-159. 10.1080/02841860802266672, 18752082.
10. Singhal N, Kotasek D, Parnis FX. Response to erlotinib in a patient with treatment refractory chordoma. Anticancer Drugs 2009, 20:953-955. 10.1097/CAD.0b013e328330c7f0, 19730087.
11. Yang C, Schwab JH, Schoenfeld AJ, Hornicek FJ, Wood KB, Nielsen GP, Choy E, Mankin H, Duan Z. A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther 2009, 8:2597-2605. 10.1158/1535-7163.MCT-09-0504, 19723879.
12. Ostroumov E, Hunter CJ. Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein. Spine (Phila Pa 1976) 2008, 33:2774-2780.
13. Presneau N, Shalaby A, Ye H, Pillay N, Halai D, Idowu B, Tirabosco R, Whitwell D, Jacques TS, Kindblom LG, Bruderlein S, Moller P, Leithner A, Liegl B, Amary FM, Athanasou NN, Hogendoorn PC, Mertens F, Szuhai K, Flanagan AM. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 2011, 223:327-335. 10.1002/path.2816, 21171078.
14. Weinberger PM, Yu Z, Kowalski D, Joe J, Manger P, Psyrri A, Sasaki CT. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Arch Otolaryngol Head Neck Surg 2005, 131:707-711. 10.1001/archotol.131.8.707, 16103303.
15. Ptaszynski K, Szumera-Cieckiewicz A, Owczarek J, Mrozkowiak A, Pekul M, Baranska J, Rutkowski P. Epidermal growth factor receptor (EGFR) status in chordoma. Pol J Pathol 2009, 60:81-87.
16. Tamborini E, Virdis E, Negri T, Orsenigo M, Brich S, Conca E, Gronchi A, Stacchiotti S, Manenti G, Casali PG, Pierotti MA, Pilotti S. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. Neuro Oncol 2010, 12:776-789. 10.1093/neuonc/noq003, 2940683, 20164240.
17. Shalaby A, Presneau N, Ye H, Halai D, Berisha F, Idowu B, Leithner A, Liegl B, Briggs TR, Bacsi K, Kindblom LG, Athanasou N, Amary MF, Hogendoorn PC, Tirabosco R, Flanagan AM. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol 2011, 223:336-346. 10.1002/path.2818, 21171079.
18. Walter BA, Begnami M, Valera VA, Santi M, Rushing EJ, Quezado M. Gain of chromosome 7 by chromogenic in situ hybridization (CISH) in chordomas is correlated to c-MET expression. J Neurooncol 2011, 101:199-206. 10.1007/s11060-010-0250-5, 20617367.